Stay updated on Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.4 to v3.6.5, indicating a software version update that changes internal metadata without altering study details or visible content.
    Difference
    0.0%
    Check dated 2026-08-12T21:38:09.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision metadata was updated from v3.6.3 to v3.6.4, indicating an internal update to the page. The visible study details and layout appear unchanged.
    Difference
    0.0%
    Check dated 2026-07-22T10:29:03.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3. This reflects a minor backend/template update and does not alter study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-01T02:48:33.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page revision label changed from v3.5.4 to v3.5.5, indicating a minor version update to the document.
    Difference
    0.0%
    Check dated 2026-06-09T16:44:32.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.5.3 to v3.5.4, indicating an update to the site's frontend template used for displaying the study details. There are no visible changes to study information or page layout described by the provided data.
    Difference
    0.0%
    Check dated 2026-05-19T10:25:47.000Z thumbnail image
  8. Check
    113 days ago
    Change Detected
    Summary
    A new revision tag v3.5.3 was added and the previous v3.5.0 tag was removed, indicating an administrative update to the study record's revision history. This update does not affect study data, eligibility criteria, or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-27T19:32:47.000Z thumbnail image

Stay in the know with updates to Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ofatumumab vs Teriflunomide in Relapsing MS Clinical Trial page.